LYRA
NASDAQ · Pharmaceuticals
Lyra Therapeutics Inc
$0.57
-0.11 (-16.18%)
Open$0.60
Previous Close$0.68
Day High$0.65
Day Low$0.44
52W High$14.88
52W Low$0.31
Volume—
Avg Volume15.7K
Market Cap1.21M
P/E Ratio—
EPS$-19.31
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+2,356.1% upside
Current
$0.57
$0.57
Target
$14.00
$14.00
$9.32
$14.00 avg
$16.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 448.1K | 675.0K | 681.7K |
| Net Income | -32,561,827 | -44,141,654 | 169.3K |
| Profit Margin | -7,266.1% | -6,902.8% | 24.8% |
| EBITDA | -34,412,962 | -49,242,828 | 337.6K |
| Free Cash Flow | — | — | 110.0K |
| Rev Growth | -33.6% | -33.6% | +3.7% |
| Debt/Equity | — | — | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |